Biotech & Health
Life Biosciences Doses First Patient in Aging Reversal Trial
For the first time, a human patient has received an injection designed to partially reprogram their cells, aiming to reverse age-related blindness rather than just treat its symptoms.
Lena Petrova·June 12, 2026
